Navigation Links
OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial
Date:5/30/2009

others, the possibility that any benefit in patient survival will not be maintained or will become less substantial as patient survival follow up continues, risks that clinical trials will not be successful or confirm earlier clinical trial results, including the risk that the survival benefit will not be confirmed by a Phase 3 clinical trial, risks associated with obtaining funding from third parties or completing a financing necessary to support the costs and expenses of a Phase 3 clinical trial, the timing and costs of clinical trials and regulatory approvals will be different than management currently anticipates, risks relating to the development, safety and efficacy of therapeutic drugs and potential applications for these products and the risk factors set forth in the Company's filings with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for fiscal year 2008. The Company undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof.


'/>"/>
SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. OncoGenex Pharmaceuticals to Webcast ASCO Reception on May 30, 2009
2. OncoGenex Pharmaceuticals Announces Release of Two ASCO Abstracts: Impact of OGX-011 on Survival in Randomized Phase 2 Trial and Phase 1 Safety Data for OGX-427
3. OncoGenex Pharmaceuticals Clinical Programs to be Featured in Oral Presentations at the American Society of Clinical Oncology Annual Meeting
4. OncoGenex Reports First Quarter Financial Results
5. OncoGenex Pharmaceuticals to Release First Quarter Financial Results
6. OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer
7. OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia
8. OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009
9. OncoGenex Pharmaceuticals to Webcast Financial Results for Fourth Quarter and Fiscal Year 2008 and Provide Outlook for 2009
10. OncoGenex Provides Update on Two-Year Survival Data from Ongoing Phase 1/2 Clinical Trial of OGX-011 in Non-Small Cell Lung Cancer
11. OncoGenex To Present At The RBC Capital Markets 2008 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... -- Research and Markets  has announced the addition of ... Business Report" report to their offering. ... Cells (SOFCs) in US$ Thousands. The report provides separate comprehensive ... Europe , Asia-Pacific , and ... the period 2012 through 2020. Market data and analytics are ...
(Date:8/19/2014)... CSSi, the leader in patient recruitment solutions ... of the company,s Medical and Clinical Advisory Board ("MCAB") ... William E. Gannon, Jr. to the MCAB. ... The MCAB, with Dr. Gannon,s leadership, will help ... set strategic goals for the advancement and development of ...
(Date:8/19/2014)... Scottsdale, AZ (PRWEB) August 19, 2014 ... the launch of its online sales skills training ... their sales skills. , MedTech clinical staff spend the ... at a hospital, standalone medical center, or physician practice ... administrative staff. But why stop there? Sales Horizons believes ...
(Date:8/18/2014)... 2014 BioElectronics Corporation (OTC Pink: ... devices said that its EVP Dr. ... as part of its Executive Interview Series. ... at http://ceolive.tv/bioelectronics-corp-otc-biel/biel-videos/2282-ceolive-tv-interview-bioelectronics-corp-otcqb-biel In ... the unique advantages of BioElectronics patented technology ...
Breaking Biology Technology:Global Solid Oxide Fuel Cells (SOFCs) - Strategic Business Report 2014 2CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 2CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 3Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 2Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 3BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 2BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 3
... Edwards Lifesciences,Corporation (NYSE: EW ), the world ... the first three human implants of the next-generation,Edwards ... M.D.,director of the cath lab and cardiac intervention ... "Edwards is proud to extend our leadership in ...
... of Phase 3 ... in BPH ... dollars, QUEBEC CITY, March 5 /PRNewswire-FirstCall/ - Aeterna Zentaris Inc.,(NASDAQ: AEZS ... financial and operating results,for the fourth quarter and full year ended December 31, ...
... assistant professor of electrical and computer engineering at ... Faculty Early Career Development Award from the National ... exciting next evolution of electronics known as spintronics. ... magnet-like spin property of electrons to produce electronics ...
Cached Biology Technology:Edwards Lifesciences Announces First Human Implants of Next-Generation Transcatheter Heart Valve 2Edwards Lifesciences Announces First Human Implants of Next-Generation Transcatheter Heart Valve 3Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results 2Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results 3Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results 4Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results 5Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results 6Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results 7Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results 8UD's Appelbaum wins NSF Career Award for research on silicon spintronics 2UD's Appelbaum wins NSF Career Award for research on silicon spintronics 3
(Date:8/20/2014)... POINT ROBERTS, Washington , August 20, 2014 ... Role in Addressing Security Concerns in the Payment Industry? ... source covering leading sectors including biometrics, issues commentary from analysts ... Jason Peaslee , Managing Partner at Thrive Analytics, ... Pereira , CEO of NXT-ID, Inc. (OTCBB: NXTD) ( OTCQB:NXTD ...
(Date:8/19/2014)... improve students, chances of completing introductory biology courses ... (UH) implemented a comprehensive student success program, employing ... , Through a grant from the Texas ... Biology and Biochemistry embarked on a pilot program ... non-majors and "Introductory Biology" for science majors. These ...
(Date:8/19/2014)... week,s Eos: Long-Term Ecological Research and Network-Level Science, , ... a wide range of ecosystems was responding to global ... particularly powerful if it coupled multiple decades of information ... experiments and models from dozens of different ecosystem types. ... the Long-Term Ecological Research (LTER) Network, which will soon ...
Breaking Biology News(10 mins):Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 2Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 3Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 4Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 5Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 6Digital Wallets for a Digital World - the Players and the Concerns for Consumer Adoption 7University of Houson program earns kudos for improving grades, retaining students 2University of Houson program earns kudos for improving grades, retaining students 3This week from AGU: Long-term ecological research, predicting cholera outbreaks 2
... color is one of its more impressive tricks. It is ... as lighting conditions change. Sarah Allred, an assistant ... from the University of Pennsylvania on groundbreaking research that provides ... the research with Alan L. Gilchrist, a professor of psychology ...
... 15 November 2011 Farmer trainers should be selected based ... on their successes in implementing farming techniques, shows a new ... Agroforestry Centre (ICRAF). , In the study by Franzel, Charles ... leguminous shrubs for feeding dairy cows, in Kenya took part ...
... German . Supplied with sufficient energy, a ... But nature also knows systems whose dynamics suddenly turn into a ... caught up in such a system would continue running, but without ... have now succeeded in building a simple model system consisting of ...
Cached Biology News:Rutgers-Camden researcher examines how the brain perceives shades of gray 2Rutgers-Camden researcher examines how the brain perceives shades of gray 3Teaching skills key to selection of a successful model farmer 2Perfect micro rings woven from muscle fibers 2Perfect micro rings woven from muscle fibers 3
... preparations are prepared from customers high-copy ... to multi-gram scales. Small-scale (1-100mg) ... are made according to customer specifications. ... to customer needs, and glycerol stocks ...
... can operate as a Voltage Clamp, as a ... in electrophysiology research applications. Performance in any ... equipment. This amazing instrument is made possible ... Digital Signal Processing (DSP) integrated circuit chips. Until ...
... The Ph.D. Peptide Display Cloning System facilitates ... the surface of bacteriophage M13 as coat ... each displayed peptide and its encoding DNA ... targets can then be selected by the ...
... A key to successful cell culture ... nutrient composition during the process, and make ... the composition. Nova BioProfile Chemistry Analyzers provide ... gases in cell culture and fermentation media. ...
Biology Products: